Trial Profile
A prospective, double-blind, randomised trial to assess the efficacy of continuous sciatic/posterior tibial blockade via a neural sheath catheter in lower limb amputees
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Levobupivacaine (Primary)
- Indications Phantom limb pain; Postoperative pain
- Focus Therapeutic Use
- 24 Aug 2021 Planned number of patients changed from 86 to 132.
- 17 Oct 2014 Accrual to date is 104% according to United Kingdom Clinical Research Network.
- 17 Oct 2014 Planned number of patients changed from 176 to 86 as reported by United Kingdom Clinical Research Network.